Insider Transactions in Q3 2023 at Johnson & Johnson (JNJ)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 23
2023
|
Joseph J Wolk Exec VP, CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
67
-0.13%
|
-
|
|
Aug 23
2023
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,035
-3.49%
|
-
|
|
Aug 23
2023
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
232
-0.23%
|
-
|
|
Aug 23
2023
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,787
-5.08%
|
-
|
|
Aug 23
2023
|
William Hait EVP, Chief EI and Med Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
696
-0.79%
|
-
|
|
Jul 26
2023
|
William Hait EVP, Chief EI and Med Officer |
SELL
Open market or private sale
|
Direct |
14,698
-14.35%
|
$2,528,056
$172.0 P/Share
|
|
Jul 26
2023
|
William Hait EVP, Chief EI and Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,698
+12.55%
|
$1,322,820
$90.44 P/Share
|
|
Jul 25
2023
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
20,000
-16.3%
|
$3,400,000
$170.32 P/Share
|